William W. Sims
Keine laufenden Positionen mehr
Profil
William W.
Sims joined Perlegen Sciences, Inc. as Chief Financial Officer in June 2004.
He was Chief Financial Officer of Clontech Laboratories and the Palo Alto Medical Foundation.
He received an MBA from the Stanford University Graduate School of Business and a BS from Oregon State University.
He is a Certified Public Accountant.
Ehemalige bekannte Positionen von William W. Sims
| Unternehmen | Position | Ende |
|---|---|---|
Perlegen Sciences, Inc.
 Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Finanzdirektor/CFO | - |
Ausbildung von William W. Sims
| Stanford University | Masters Business Admin |
| Oregon State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Perlegen Sciences, Inc.
Perlegen Sciences, Inc. Drugstore ChainsRetail Trade Perlegen Sciences, Inc. discovers and develops drugs. Its product pipeline consists of targeted drug candidates addressing type II diabetes and dyslipidemia markets. The company's products include PGX-510 and PGX-520. It operates in the United States, European Union, and Japan. Perlegen Sciences was co-founded by Brad A. Margus, David R. Cox, and Stephen P. A. Fodor in 2000 and is headquartered in Mountain View, CA | Retail Trade |
